EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS)

Jennifer L Kim iD, Kanah M Lewallen, Emily K Hollingsworth iD, Avantika S Shah iD, Sandra F Simmons, Eduard E Vasilevskis iD

The Gerontologist · 2023

DOI: 10.1093/geront/gnac100 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Gerontologist, 2023. Verfasst von Jennifer L Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Quality Aging, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Deprescriptions. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Effective deprescribing requires shared decision making between a patient and their clinician, and should be used when implementing evidence-based deprescribing conversations. As part of the Shed-MEDS clinical trial, this study assessed barriers and enablers that influence patient decision making in deprescribing to inform future implementation efforts and adaptations. Research Design and Methods Shed-MEDS, a randomized controlled deprescribing trial, included hospitalized older adults discharging to post-acute care facilities. A trained clinician reviewed each participant’s medical history and medication list to identify medications with potential for deprescribing. The study clinician then conducted a semistructured patient-centered deprescribing interview to determine patient (or surrogate) concerns about medications and willingness to deprescribe. Reeve et al.’s (2013) framework was used to categorize barriers and enablers to deprescribing from the patient’s perspective, including “appropriateness of cessation,” “fear,” “dislike of a medication,” “influences,” and “process of cessation.” Results Overall, participants/surrogates (N = 177) agreed with 63% (883 total medications) of the study clinician’s deprescribing recommendations. Thematic analysis revealed that “appropriateness” of a medication was the most common barrier (88.2%) and enabler (67.3%) to deprescribing. Other deprescribing enablers were in the following domains: “influences” (22.7%), “process” (22.5%), “pragmatic” (19.4%), and “dislike” (5.3%). Discussion and Implications Use of a semistructured deprescribing interview conversation tool allowed study clinicians to elicit individual barriers and enablers to deprescribing from the patient’s perspective. Participants in this study expressed more agreement than disagreement with study clinicians’ deprescribing recommendations. These results should inform future implementation efforts that incorporate a patient-centered framework during deprescribing conversations. Clinical Trials Registration Number NCT02979353

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsHumansAgedPatient DischargeDecision Making, SharedDissent and DisputesPatient Reported Outcome Measures

Stichwörter der Autor:innen

Patient-centeredPolypharmacyShared decision making

Autor:innen und Institutionen

  • Center for Quality Aging, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • School of Nursing, Vanderbilt University, Nashville, Tennessee, USA.
  • Geriatric Research, Education, & Clinical Center (GRECC), VA Tennessee Healthcare System, Nashville, Tennessee, USA.
  • Section of Hospital Medicine, Division of General Internal Medicine & Public Health, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Jennifer L Kim, Emily K Hollingsworth, Avantika S Shah, Eduard E Vasilevskis

Förderung

  • HSRD VA
  • NIA NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Kim, J. L., Lewallen, K. M., Hollingsworth, E. K., Shah, A. S., Simmons, S. F., & Vasilevskis, E. E. (2023). Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS). The Gerontologist. https://doi.org/10.1093/geront/gnac100

Vancouver

Kim JL, Lewallen KM, Hollingsworth EK, Shah AS, Simmons SF, Vasilevskis EE. Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS). The Gerontologist. 2023. doi:10.1093/geront/gnac100

BibTeX
@article{Kim2023,
  author = {Kim, Jennifer L and Lewallen, Kanah M and Hollingsworth, Emily K and Shah, Avantika S and Simmons, Sandra F and Vasilevskis, Eduard E},
  title = {Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS)},
  journal = {The Gerontologist},
  year = {2023},
  doi = {10.1093/geront/gnac100}
}
Kostenlos starten →